BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE Test
Cost: AED 1000.0
Test Components
- Price: 1000.0 AED
- Sample Condition: 5 mL (3 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery
Sample: Mon / Wed / Fri by 9 am
Report: Tue / Thu / Sat
Method
Real Time PCR
Test Type
Leukemia
Doctor
Oncologist, Hematologist
Test Department
MOLECULAR DIAGNOSTICS
Pre Test Information
No special preparation required
Test Details
The BCR-ABL gene rearrangement PCR qualitative test is a diagnostic tool used to detect the presence of a specific genetic abnormality called the BCR-ABL gene rearrangement. This abnormality is commonly found in patients with chronic myeloid leukemia (CML) and a small percentage of patients with acute lymphoblastic leukemia (ALL).
The test involves extracting DNA from a patient’s blood or bone marrow sample and amplifying specific regions of the BCR and ABL genes using the polymerase chain reaction (PCR) technique. The PCR amplification allows for the detection of any rearrangements or mutations in the BCR-ABL gene.
A positive result indicates the presence of the BCR-ABL gene rearrangement, confirming the diagnosis of CML or ALL. This information is crucial for determining appropriate treatment options and monitoring the response to therapy.
It is important to note that this test is qualitative, meaning it only provides a yes or no answer regarding the presence of the BCR-ABL gene rearrangement. It does not provide information about the quantity or level of the abnormal gene. For quantitative assessment, a separate test called the BCR-ABL quantitative PCR test is performed.
Test Name | BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE Test |
---|---|
Components | |
Price | 1000.0 AED |
Sample Condition | 5 mL (3 mL min.) whole blood \/ Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. |
Report Delivery | SampleMon / Wed / Fri by 9 am; Report Tue / Thu / Sat |
Method | Real Time PCR |
Test type | Leukemia |
Doctor | Oncologist, Hematologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | No special preparation required |
Test Details | The BCR-ABL gene rearrangement PCR qualitative test is a diagnostic tool used to detect the presence of a specific genetic abnormality called the BCR-ABL gene rearrangement. This abnormality is commonly found in patients with chronic myeloid leukemia (CML) and a small percentage of patients with acute lymphoblastic leukemia (ALL). The test involves extracting DNA from a patient’s blood or bone marrow sample and amplifying specific regions of the BCR and ABL genes using the polymerase chain reaction (PCR) technique. The PCR amplification allows for the detection of any rearrangements or mutations in the BCR-ABL gene. A positive result indicates the presence of the BCR-ABL gene rearrangement, confirming the diagnosis of CML or ALL. This information is crucial for determining appropriate treatment options and monitoring the response to therapy. It is important to note that this test is qualitative, meaning it only provides a yes or no answer regarding the presence of the BCR-ABL gene rearrangement. It does not provide information about the quantity or level of the abnormal gene. For quantitative assessment, a separate test called the BCR-ABL quantitative PCR test is performed. |